Superworth

Chemours free cash flow CC

Cash from operations less capital spending, by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
n/m
a quarter missing
Latest quarter, Q2 FY26
$114M
+128% on a year earlier
Fiscal year 2024
−$993M
−634% on the year before

Chemours' twelve-month free cash flow can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was $114M, up 128% on the same quarter a year before.

Free cash flow over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearFree cash flowChange
FY2024−$993M−634%
FY2023$186M−58%
FY2022$448M−17%
FY2021$543M+1%
FY2020$540M+220%
FY2019$169M−74%
FY2018$642M+180%
FY2017$229M−11%
FY2016$256Mn/a
FY2015−$337Mn/a
FY2014n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedFree cash flowOn a year earlierLast 12 months
Q2 FY26$114M+128%n/a
Q1 FY26−$93Mn/an/a
Q3 FY25$105M+67%−$12M
Q2 FY25$50Mn/a−$54M
Q1 FY25−$196Mn/a−$797M
Q4 FY24$29M−92%−$993M
Q3 FY24$63M+40%−$675M
Q2 FY24−$693M−7800%−$693M
Q1 FY24−$392Mn/a$9M
Q4 FY23$347M+269%$186M
Q3 FY23$45M−80%−$67M
Q2 FY23$9M−96%$117M

Against its peers

Companies in Chemicals nearest Chemours' size, closest first, today.

CompanyFree cash flow yield
CCChemoursn/m
ROGRogers3.7%
NGVTIngevity6.5%
IOSPInnospec2.9%
FULFuller H B3.7%
WDFCWD 402.8%
CRONCronos4.0%
AVNTAvient5.1%
CBTCabot7.4%
FTKFlotek Industries−0.5%
CSWCSW Industrials3.0%
Peer median3.7%

What the free cash flow tells you

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

More on Chemours

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.